Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck to acquire oncology firm VelosBio for $2.75bn

pharmaceutical-technologyNovember 09, 2020

Tag: Merck , VelosBio , Oncology

PharmaSources Customer Service